Therapeutic Advances in Psychopharmacology
Q1 Journal
Open Access
Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Pharmacology (medical)
Q1
└
Psychiatry and Mental Health
Q1
Publisher
SJR 2025
1.321
Q1
SJR Score
H-Index
52
Citations / Doc (2yr)
4.39
Total Docs. (latest)
34
Total Citations (3yr)
461
Publication type
Journals
ISSN
20451261, 20451253
Coverage
2011-2026
Journal Rank
#3,070
Subject Categories
Pharmacology (medical)
Q1
Psychiatry and Mental Health
Q1
Subject Areas
Aims & Scope
Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology.
The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in psychopharmacology, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of psychopharmacology.
The journal is dedicated to publishing clinical research.
We do not publish preclinical research, including basic laboratory research and animal studies.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 34 |
| Total Docs. (3 years) | 111 |
| Total Refs. | 1,838 |
| Total Citations (3 years) | 461 |
| Citable Docs. (3 years) | 103 |
| Citations / Doc. (2 years) | 4.39 |
| Ref. / Doc. | 54.06 |
| % Female | 39.8% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.